Visiting Analyst at Nina Capital
Check size: Nina Capital does not publish one standard current check-size range on its official site.
Guillem Torruella invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-driven, value-based Biodesign approach..
Lead with the unmet need, stakeholders, evidence, workflow and economic value, regulatory path, team and the milestone to Series A readiness.
Deeply understood healthcare needs, evidence of stakeholder value, thoughtful teams and technology capable of international impact.
Technology in search of a healthcare need, weak clinical or economic value, and companies outside the published geographies are less aligned.